Westfuller Advisors’s Astrana Health ASTH Stock Holding History

Westfuller Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27	Closed	-$773	–	823
2025 Q3	$773	Buy	+27	New	+$732	﹤0.01%	722

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Westfuller Advisors's ASTH Position: Q4 2025 in Review

Westfuller Advisors sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 27 shares — an estimated $773 sold.

Westfuller Advisors first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $773 in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

Westfuller Advisors reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
Westfuller Advisors sold 27 Astrana Health shares in Q4 2025, an estimated $773.
Westfuller Advisors first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
Westfuller Advisors's Astrana Health position peaked at $773 in Q3 2025.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Westfuller Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.